<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, April 29, 2019 (HealthDay News) — Structured support for patients transitioning from pediatric to adult care for type 1 diabetes may improve outcomes, but those benefits are not sustained after completion of the intervention, according to a study published online April 22 in Diabetes Care<\/i>.<\/p>\n
Tamara Spaic, M.D., from St. Joseph’s Health Care London in Ontario, Canada, and colleagues randomly assigned 205 young adults (ages 17 to 20 years) with type 1 diabetes to a transition program or standard care. The transition intervention included a transition coordinator and lasted 18 months (six months in pediatric care and 12 months in adult care).<\/p>\n
The researchers found that those in the transition program had higher clinic attendance (P = 0.002), greater satisfaction with care (P = 0.032), and less diabetes-related distress (P = 0.049) versus those in standard care. There was also a trend toward improvement in mean hemoglobin A1c (HbA1c; P = 0.057) associated with the transition program. However, during the 12-month follow-up period, there was no difference between the groups for failing to attend at least one clinic visit (P = 0.846) or mean change in HbA1c (P = 0.073). At the end of follow-up, there were no differences between the groups with respect to satisfaction with care, diabetes-related distress, or quality of life.<\/p>\n
“We anticipate that the results of this appropriately powered randomized controlled trial will help to inform a more complete and prolonged solution for transition,” the authors write.<\/p>\n
Two authors disclosed financial ties to pharmaceutical and medical device companies.<\/p>\n
Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n